Thus, simvastatin appears to negatively regulate activation of PI3K/Akt and further block mTOR→S6 ribosomal protein and →4E-BP1 signalling cascades in breast cancer cells. The gene discussed is EIF4EBP1; the disease is breast carcinoma.